No profile data available.
Idexx Laboratories, Inc. (IDXX) is a healthcare company in the animal healthcare items industry, based in Westbrook, United States, with about 11,000 full-time employees.
It reported revenue of $4.30 billion for fiscal year 2025, up 10.4% from fiscal year 2024, and net income of $1.06 billion. In Q2 2026 (the quarter ended June 30, 2026) revenue was $1.22 billion, up 9.7% from a year before. Its largest business segment, Companion Animal Group, brought in 92% of segment revenue in fiscal year 2025; United States was the largest region with 64%. Its market capitalization was $40.86 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.
Idexx Laboratories reported $4.30 billion in revenue for fiscal year 2025, up 10.4% from $3.90 billion in fiscal year 2024. In Q2 2026 revenue was $1.22 billion.
Companion Animal Group, with $3.95 billion or 92% of segment revenue in fiscal year 2025. Next: Water (5%) and Livestock, Poultry and Dairy (3%).
United States: 64% of revenue by region in fiscal year 2025, followed by Other Europe, The Middle East and Africa (5%).
$40.86 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (animal healthcare items) include Zoetis Inc. (ZTS), Elanco Animal Health Incorporated (ELAN), Phibro Animal Health Corporation (PAHC), ImmuCell Corporation (ICCC).